Search Results - "LAWRENCE, K. M"

Refine Results
  1. 1

    Chondroprotection by urocortin involves blockade of the mechanosensitive ion channel Piezo1 by Lawrence, K. M., Jones, R. C., Jackson, T. R., Baylie, R. L., Abbott, B., Bruhn-Olszewska, B., Board, T. N., Locke, I. C., Richardson, S. M., Townsend, P. A.

    Published in Scientific reports (11-07-2017)
    “…Osteoarthritis (OA) is characterised by progressive destruction of articular cartilage and chondrocyte cell death. Here, we show the expression of the…”
    Get full text
    Journal Article
  2. 2

    Locally advanced rectal cancer : histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy by JOHNSTON, D. F, LAWRENCE, K. M, SIZER, B. F, ARULAMPALAM, T. H. A, MOTSON, R. W, DOVE, E, LACEY, N

    Published in British journal of radiology (01-04-2009)
    “…The accuracy of MRI after long-course chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC) has been questioned. We have evaluated our experience of…”
    Get full text
    Journal Article
  3. 3

    The Urocortins: mechanisms of cardioprotection and therapeutic potential by Lawrence, K M, Latchman, D S

    Published in Mini reviews in medicinal chemistry (01-10-2006)
    “…The study of the Urocortin family of peptides is becoming increasingly important clinically, as new discoveries have revealed that their roles in the body are…”
    Get more information
    Journal Article
  4. 4

    Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes by Chanalaris, A., Lawrence, K.M., Stephanou, A., Knight, R.D., Hsu, S.Y., Hsueh, A.J.W., Latchman, D.S.

    “…Urocortin (UCN), a member of the Corticotropin-Releasing Factor (CRF) family of peptides is a well described cardioprotective agent. UCN is able to bind to two…”
    Get full text
    Journal Article
  5. 5

    Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based tunel technique enhanced with counterstains by Scarabelli, T.M, Knight, R.A, Rayment, N.B, Cooper, T.J, Stephanou, A, Brar, B.K, Lawrence, K.M, Santilli, G, Latchman, D.S, Baxter, G.F, Yellon, D.M

    Published in Journal of immunological methods (31-08-1999)
    “…Apoptosis is a distinct form of cell death, induced, for example, by ischaemia/reperfusion injury, that results in characteristic alterations in cell…”
    Get full text
    Journal Article
  6. 6

    Urocortin – From Parkinson's disease to the skeleton by Lawrence, K.M., Jackson, T.R., Jamieson, D., Stevens, A., Owens, G., Sayan, B.S., Locke, I.C., Townsend, P.A.

    “…Urocortin (Ucn 1), a 40 amino acid long peptide related to corticotropin releasing factor (CRF) was discovered 19 years ago, based on its sequence homology to…”
    Get full text
    Journal Article
  7. 7

    Urocortin protects chondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis? by Intekhab-Alam, N Y, White, O B, Getting, S J, Petsa, A, Knight, R A, Chowdrey, H S, Townsend, P A, Lawrence, K M, Locke, I C

    Published in Cell death & disease (01-07-2013)
    “…Osteoarthritis (OA) is characterized by a loss of joint mobility and pain resulting from progressive destruction and loss of articular cartilage secondary to…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium insensitive phospholipase A2 gene expression by Lawrence, Kevin M., Scarabelli, Tiziano M., Turtle, Lance, Chanalaris, Anastasios, Townsend, Paul A., Carroll, Christopher J., Hubank, Mike, Stephanou, Anastasis, Knight, Richard A., Latchman, David S.

    Published in The FASEB journal (01-12-2003)
    “…ABSTRACT We have used Affymetrix gene chip technology to look for changes in gene expression caused by a 24 h exposure of rat primary neonatal cardiac myocytes…”
    Get full text
    Journal Article
  11. 11

    Alpha-1-acid glycoprotein in major depressive and eating disorders by Healy, D, Calvin, J, Whitehouse, A M, White, W, Wilton-Cox, H, Theodorou, A E, Lawrence, K M, Horton, R W, Paykel, E S

    Published in Journal of affective disorders (01-05-1991)
    “…Plasma alpha 1-acid glycoprotein (AGP) levels were measured in 49 subjects with major depressive disorder, 15 subjects with anorexia nervosa and 18 subjects…”
    Get more information
    Journal Article
  12. 12

    [ 3H] Imipramine binding in brain samples from depressed suicides and controls: 5-HT uptake sites compared with sites defined by desmethylimipramine by Lawrence, Kevin M., Kanagasundaram, Mohan, Lowther, Sandra, Katona, Cornelius L.E., Crompton, M.Rufus, Horton, Roger W.

    Published in Journal of affective disorders (1998)
    “…Using desmethylimipramine (DMI) defined and Na + dependent [ 3H]imipramine binding, we have examined both 5-HT uptake sites and sites unrelated to 5-HT uptake,…”
    Get full text
    Journal Article
  13. 13

    K(ATP) channel gene expression is induced by urocortin and mediates its cardioprotective effect by Lawrence, K M, Chanalaris, A, Scarabelli, T, Hubank, M, Pasini, E, Townsend, P A, Comini, L, Ferrari, R, Tinker, A, Stephanou, A, Knight, R A, Latchman, D S

    Published in Circulation (New York, N.Y.) (17-09-2002)
    “…Urocortin is a novel cardioprotective agent that can protect cardiac myocytes from the damaging effects of ischemia/reperfusion both in culture and in the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Enhanced displacement of [ [formula omitted]]imipramine, but not [ [formula omitted]]paroxetine binding by plasma from depressed patients by Lawrence, Kevin M, Lowther, Sandra, Falkowski, Jan, Jacobson, Robin R, Horton, Roger W

    Published in Journal of affective disorders (01-11-1997)
    “…Plasma from healthy subjects inhibited the binding of [ 3 H ]imipramine competitively and [ 3 H ]paroxetine non-competitively to platelet membranes in a…”
    Get full text
    Journal Article
  16. 16

    Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls by LAWRENCE, K. M, DE PAERMENTIER, F, LOWTHER, S, CROMPTON, M. R, KATONA, C. L. E, HORTON, R. W

    Published in Journal of psychiatry & neuroscience (01-05-1997)
    “…Saturation binding of [3H]paroxetine was performed in 10 brain regions from a group of suicide victims who had a firm, retrospective diagnosis of depression…”
    Get full text
    Journal Article
  17. 17

    CRH-like peptides protect cardiac myocytes from lethal ischaemic injury by Brar, Bhawanjit K, Stephanou, Anastasis, Okosi, Anne, Lawrence, Kevin M, Knight, Richard A, Marber, Michael S, Latchman, David S

    Published in Molecular and cellular endocrinology (20-12-1999)
    “…Simulated ischaemia causes both necrotic and apoptotic death of primary cultures of neonatal rat cardiac myocytes. Simulated ischaemia is associated with…”
    Get full text
    Journal Article
  18. 18

    Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine by LAWRENCE, K. M, KATONA, C. L. E, ABOU-SALEH, M. T, ROBERTSON, M. M, NAIRAC, B. L, EDWARDS, D. R. L, BURNS, R. A, HARRISON, D. A, HORTON, R. W

    Published in Psychopharmacologia (01-06-1994)
    “…Platelet [3H] paroxetine binding was measured in 73 depressed patients and in 64 healthy volunteers. No differences were found in Bmax or Kd either overall, or…”
    Get full text
    Journal Article
  19. 19

    Investigating the endothelin receptor antagonist aprocitentan in resistant hypertension: design and baseline characteristics of the PRECISION study by Danaietash, P, Verweij, P, Wang, J, Dresser, G, Kantola, I, Lawrence, M K, Narkiewicz, K, Schlaich, M, Bellet, M

    Published in European heart journal (12-10-2021)
    “…Abstract   The endothelin (ET) system plays an important role in hypertension, especially in volume and salt-dependent forms, which are common in patients with…”
    Get full text
    Journal Article
  20. 20

    Growth hormone and physiological responses to clonidine in depression by Katona, C L, Healy, D, Paykel, E S, Theodorou, A E, Lawrence, K M, Whitehouse, A, White, B, Horton, R W

    Published in Psychological medicine (01-02-1993)
    “…Clonidine (1.3 micrograms/kg) was administered to 62 control and 55 depressed patients free of psychoactive drugs for at least 7 days and fasted overnight…”
    Get more information
    Journal Article